Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Comparative in vitro and in vivo activity of temocillin (BRL 17421) and ampicillin against Haemophilus influenzae type b
R. Yogev
, W. Glogowski, E. Connor
Pediatrics
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Comparative in vitro and in vivo activity of temocillin (BRL 17421) and ampicillin against Haemophilus influenzae type b'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
In Vivo Activity
100%
Ampicillin
100%
Haemophilus Influenzae Type b
100%
Temocillin
100%
Minimum Inhibitory Concentration
50%
Bacteremia
25%
Pediatric Patients
25%
Cure Rate
25%
Difference in Mean
25%
β-lactamase
25%
Meningitis
25%
Haemophilus Influenzae
25%
Infant Rat
25%
Ampicillin Resistance
25%
H. Influenzae Type b
25%
Non-producer
25%
New Cephalosporin
25%
Pharmacology, Toxicology and Pharmaceutical Science
Ampicillin
100%
Haemophilus Influenzae Type B
100%
Temocillin
100%
Haemophilus influenzae
50%
Infection
25%
Bloodstream Infection
25%
Meningitis
25%
Penicillinase
25%
Cephalosporin Derivative
25%
Immunology and Microbiology
Haemophilus influenzae
100%
Haemophilus Influenzae Type B
100%
Minimum Inhibitory Concentration
50%
MIC90
50%
Meningitis
50%